Clinical Laserthermia Systems AB (publ) (CLS-B.ST)
Stockholm · SEK · Healthcare · Medical Devices
SEK 1.78 (+3.01%) as of
Key statistics
- Market cap
- 86.27M
- Forward P/E
- -3.56
- EPS (TTM)
- -1.3000
- Dividend yield
- 0.00%
- 52-week range
- 1.6700 – 9.9800
- Beta
- -0.14
- Revenue (TTM)
- 12.56M
- Profit margin
- 0.00%
- Analyst target
- SEK 5.50
- Volume
- 58.24k
About Clinical Laserthermia Systems AB (publ)
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control treatment. In addition, it offers various gauge laser applicators and introducers, as well as provides temperature and treatment monitoring devices. The company has a strategic partnership with ClearPoint Neuro Inc. for the development of ClearPoint Prism, a Neuro Laser Therapy System. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Lund, Sweden
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.